Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Garden Grove, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
National City, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
National City, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Norwalk, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Norwalk, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Oakland, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Oceanside, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Orange, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Pico Rivera, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Pico Rivera, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Riverside, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
San Bernardino, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
San Diego, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
San Gabriel, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
San Gabriel, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Torrance, CA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Torrance, CA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
New Haven, CT
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Atlanta, GA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Marietta, GA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Chicago, IL
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Hoffman Estates, IL
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Cedarhurst, NY
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Rochester, NY
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Desoto, TX
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Desoto, TX
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Clinical Research Facility
mi
from
Houston, TX
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated:  4/30/2018
Site Reference ID/Investigator# 117189
mi
from
Chita,
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
Long-Term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: A Double-Blind Extension Study for Subjects Completing Study M10-855
Status: Enrolling
Updated: 4/30/2018
Site Reference ID/Investigator# 117189
mi
from
Chita,
Click here to add this to my saved trials
Efficacy of Social Cognition Training in Schizophrenia
Efficacy of Social Cognition Training in Schizophrenia
Status: Enrolling
Updated:  5/1/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Efficacy of Social Cognition Training in Schizophrenia
Efficacy of Social Cognition Training in Schizophrenia
Status: Enrolling
Updated: 5/1/2018
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy of Social Cognition Training in Schizophrenia
Efficacy of Social Cognition Training in Schizophrenia
Status: Enrolling
Updated:  5/1/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Efficacy of Social Cognition Training in Schizophrenia
Efficacy of Social Cognition Training in Schizophrenia
Status: Enrolling
Updated: 5/1/2018
VA Connecticut Healthcare System
mi
from
West Haven, CT
Click here to add this to my saved trials
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
Folate Pharmacogenomics and Risk of Atypical Antipsychotic Metabolic Side Effects
Status: Enrolling
Updated:  5/1/2018
University of Michigan
mi
from
Ann Arbor, MI
Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects
Folate Pharmacogenomics and Risk of Atypical Antipsychotic Metabolic Side Effects
Status: Enrolling
Updated: 5/1/2018
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Improving Negative Symptoms of Psychosis In Real-world Environments
Improving Negative Symptoms of Psychosis In Real-world Environments
Status: Enrolling
Updated:  5/1/2018
UCSD
mi
from
La Jolla, CA
Improving Negative Symptoms of Psychosis In Real-world Environments
Improving Negative Symptoms of Psychosis In Real-world Environments
Status: Enrolling
Updated: 5/1/2018
UCSD
mi
from
La Jolla, CA
Click here to add this to my saved trials